Prognostic Factors and Risk Groups in T1G3 Non–Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients-Reference-Cited by-同舟云学术

Prognostic Factors and Risk Groups in T1G3 Non–Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients

Published:2015-01 Issue:1 Volume:67 Page:74-82
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Gontero Paolo,Sylvester Richard,Pisano Francesca,Joniau Steven,Vander Eeckt Kathy,Serretta Vincenzo,Larré Stéphane,Di Stasi Savino,Van Rhijn Bas,Witjes Alfred J.,Grotenhuis Anne J.,Kiemeney Lambertus A.,Colombo Renzo,Briganti Alberto,Babjuk Marek,Malmström Per-Uno,Oderda Marco,Irani Jacques,Malats Nuria,Baniel Jack,Mano Roy,Cai Tommaso,Cha Eugene K.,Ardelt Peter,Varkarakis John,Bartoletti Riccardo,Spahn Martin,Johansson Robert,Frea Bruno,Soukup Viktor,Xylinas Evanguelos,Dalbagni Guido,Karnes R. Jeffrey,Shariat Shahrokh F.,Palou Joan

Publisher

Elsevier BV

Subject

Urology

Reference20 articles.

1. Management of stage T1 tumors of the bladder: International Consensus Panel;Nieder;Urology,2005

2. The treated natural history of high risk superficial bladder cancer: 15-year outcome;Cookson;J Urol,1997

3. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013;Babjuk;Eur Urol,2013

4. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update;Hall;J Urol,2007

5. An updated critical analysis of the treatment strategy for newly diagnosed high-grade T1 (previously T1G3) bladder cancer;Kulkarni;Eur Urol,2010

Cited by 203 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MicroRNA-146b-5p/FDFT1 Mediates Cisplatin Sensitivity in Bladder Cancer by Redirecting Cholesterol Biosynthesis to the Non-Sterol Branch;The International Journal of Biochemistry & Cell Biology;2024-09

2. European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update;European Urology;2024-08

3. A novel laser resection approach: efficacy of rotatable bi-channel en bloc resection of bladder tumor in a pilot in-vivo study;Lasers in Medical Science;2024-07-22

4. The Potential Role of Urinary Microbiota in Bladder Carcinogenesis: A Systematic Review;UROL J;2024

5. Association Between Residual Urine Volume and Recurrence Among Patients at High Risk of Non-Muscle-Invasive Bladder Carcinoma With Versus Without Bacillus Calmette-Guérin Treatment;Cureus;2024-05-30